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A new pentacyclic stemona alkaloid, stemocurtisine (2), with a novel pyrido[1,2-
a]azepine A,B-ring system, has been isolated from a root extract of S. curtisii Hook. f.  
The structure and relative stereochemistry was determined by spectral data 
interpretation and X-ray crystallography. 
 3
  
The stemona group of alkaloids includes more than 40 different natural products that 
have been structurally classified into five different groups.1  The pyrrolo[1,2-
a]azepine (1-azabicyclo[5.3.0]decane) nucleus is common to all compounds in these 
groups.  For example, the relatively complex Stemona alkaloid, stemofoline (1), has 
the typical pyrrolo[1,2-a]azepine A,B-ring structure, characteristic of this class of 
alkaloids.2  A few of these alkaloids do not fit these five structural groups and have a 
more complex bridged structure or ring structures that most likely arises from initial 
oxidative cleavage of the pyrrolo[1,2-a]azepine ring system.1 Phytochemical studies 
on the Stemonacaeae family have been limited to eight of the recorded 30 or more 
species.1-3  Extracts of the roots of Stemona species have been used in traditional 
Chinese medicine for the treatment of various respiratory diseases and as anthelmintic 
agents for domestic animals.1,2,4-7 More recently, extracts and the pure alkaloids 
derived from the extracts of the leaves and roots of Stemona collinsae and S. tuberosa 
were shown to have insect toxicity, antifeedent, and repellent activities.2  We report 
here the isolation and structure determination of a novel Stemona alkaloid (2) from 
the root extracts of S. curtisii Hook.f. growing in the southern region of Thailand.  
This plant is known in the Thai vernacular as “non tai yak” and has received no 
phytochemical and little biological attention apart from studies of its effect on the 
action potential of the frog sciatic nerve8a and its toxicity on house fly larvae (Culex p. 
fatigans and Aedes aegypti).8b,c     
A crude ethanol extract of the roots of S. curtisii was partitioned between 5% 
hydrochloric acid solution and chloroform.  The aqueous solution was made basic 
with aqueous ammonia and extracted with chloroform.  The crude residue was 
subjected to flash column chromatography and preparative TLC to provide 2 in 0.5% 
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yield (w/w) based on the dry weight of root material.  Examination of the crude 
ethanol extract by TLC analysis showed the presence of 2, indicating that this 
compound was not being produced via an acid catalysed reaction during the acid 
extraction process. We have named this compound stemocurtisine, based on its 
botanical origin. Compound 2 was obtained as colorless prismatic crystals (mp 149-
151 oC) by careful and slow evaporation of a solution of 2 in ethyl acetate and diethyl 
ether.  HRMS (CI +ve, m/z [MH]+ 347.1727, calcd 347.1733) indicated that 2 has the 
molecular formula C19H25NO5.  The 
1H and 13C NMR specta of 2 indicated the 
presence of the C- and D-ring system that is typically found in the stemoamide group 
of alkaloids, including stemofoline (1).1,6,9-17  The 13C/DEPT NMR spectra of 2 
indicated four methine carbons, and six methylene carbons and, unlike the other 
Stemona alkaloids, except 1 and its didehydro and 2’-hydroxy derivatives,2 a 
quaternary carbon at  120.4 was apparent, indicative of a acetal-like structure (C-9).   
Indeed the corresponding acetal carbon (C-8) in 1 occurs further upfield at  112.7.2  
The X-ray structural analysis confirmed the molecular formula of 2 and revealed its 
connectivity and relative stereochemistry and showed that this alkaloid has a novel 
pentacyclic structure based on a unique pyrido[1,2-a]azepine A,B-ring system (that is 
a 6,7-bicyclic A,B-ring system) and not the typical pyrrolo[1,2-a]azepine A,B-ring 
system (5,7-bicyclic A,B-ring system).  This is the first Stemona alkaloid to have this 
type of base structure.  The absolute configuration of 2 is not known but is assumed 
based on the known configurations of Stemona alkaloids with similar C,D-ring 
structures.6,9-17  The X-ray structure of 2 also showed that the piperidine A-ring adopts 
a chair-like conformation and is connected to the B- and C-rings through an ether 
bridge between C-1 and the quaternary acetal carbon C-9 readily identified in the 13C 
NMR spectrum. 
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The full 1H and 13C NMR spectral assignments for 2, based on extensive 
COSY, TOCSY, NOESY, HMQC, and HMBC experiments, are shown in Table 1. Of 
significance in the NOESY spectra of 2 were cross peaks between H-10 and H-6, H-
6 and H-8, H-7and H-3, H-3 and H-2 and H-2 and H-4 (Figure 2).  These 
cross peaks allowed the unequivocal assignment of all methylene protons in the 1H 
NMR spectrum of 2 (Table 1) and indicated that the solution-structure of 2 is similar 
to the solid-state structure.  That is, the A-ring adopts a chair-like conformation in 
which the axial proton H-3 is in close proximity to H-7 in the seven-membered 
ring on the concave face of the molecule (Figures 1 and 2). 
In conclusion, a new pentacyclic stemona alkaloid, stemocurtisine (2), with a 
novel pyrido[1,2-a]azepine A,B-ring system has been isolated from a root extract of 
S. curtisii. 
 
Experimental Section 
General Experimental Procedures.  Melting points were determined by a 
Reichert hot-stage melting point apparatus and are uncorrected.  Optical rotations 
were measured using a JASCO DIP-370 polarimeter. IR spectra were obtained on a 
Nicolet AVATAR 300 FTIR spectrophotometer.  1H (500 MHz), 13C (75 MHz), and 
2D NMR spectra were recorded on Varian Unity 300 and 500 spectrometers. 
HRCIMS were recorded on a Fison/VG Autospec-TOF-oa Mass Spectrometer (70 
eV). 
Plant Material. The roots of Stemona curtisii were collected at 
Tumbol Kaunmao, Amphor Rasda, in the North of Trang Province, Thailand, in May 
2002.  The plant material was identified by Mr. James F. Maxwell from the 
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Department of Biology, Chiang Mai University.  A voucher specimen is deposited at 
the Herbarium (number 17581) of the Department of Biology, Chiang Mai University. 
Extraction and Isolation.  The dry ground root of S. curtisii (0.4 kg) was 
percolated with 95% ethanol (3 x 800 mL) over 3 days at room temperature.  The 
ethanolic solution was evaporated to give a dark residue (50 g) that was partitioned 
between water and chloroform. The chloroform extract was extracted with 5% 
hydrochloric acid solution and the aqueous solution was made basic with aqueous 
ammonia and extracted with chloroform to afford 0.9 g of crude alkaloid material.  
This material was chromatographed on silica gel (100 mL) using gradient elution 
from 100% dichloromethane to 50% methanol/dichloromethane containing 1% 
concentrated aqueous ammonia as eluent. A total of 1500 mL of eluent was collected 
in test tubes of 25 mL.  On the basis of TLC analysis these fractions were pooled to 
give 18 fractions. Fractions 12 (62.2 mg) and 13 (86.2 mg) were combined and re-
chromatographed by preparative TLC (dichloromethane-methanol-aqueous ammonia, 
94:5:1) to give 20.8 mg of pure stemocurtisine (2). 
 
Stemocurtisine (2): Rf 0.46 (Merck, silica gel 60 F254 TLC plates on 
aluminium backing using dichloromethane-methanol-aqueous ammonia, 94:5:1 as 
eluent) with detected using a UV-lamp and/or iodine vapour; colorless prismatic 
crystals (from EtOAc/diethyl ether); mp 149-151 oC; 25D +334o (c 0.66, CHCl3); IR 
(film) max 2932, 1741, 1618, 1021 cm-1; 1H, 13C, DEPT and HMBC NMR data are 
presented in Table 1; HREIMS m/z 347.1727 M+, calcd for C19H25NO5 347.1733.  
 
 7
X-ray Structure Determination: C19H25NO5, M = 347.4.  Trigonal, space 
group P31 )441No.,(
2
3C , a = 9.0466(6), c = 18.222(1) Å, V = 1291.5(2) Å
3.  Dc (Z = 
3) = 1.340 g cm
-3.  µMo = 0.97 cm
-1; specimen: 0.48 x 0.43 x 0.38 mm; 'T'min/max 
(multiscan absorption correction) = 0.95.  2max = 70°; Ntotal = 23659, Nunique = 3751 
(Rint = 0.037), Nobs (F > 4(F)) = 3294; R = 0.041, Rw = 0.042 (weights: (
2(F) + 
0.0002F2)-1).  |max| = 0.31(3) e Å
-3.  Bruker AXS instrument, -scans; 
monochromatic Mo K radiation,  = 0.71073 Å; T ca. 153 K.  Chirality adopted 
from chemical expectations, being indeterminate in the present experiment, with  (x, 
y, z, Uiso)H refined throughout.  CCDC # 199384. 
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Table 1.  13C NMR (75 MHz) and 1H NMR (500 Mz) Spectral Data of 2 in CDCl3 
Solution. 
Position C (DEPT) H (mult., J (Hz), 
assign.) 
HMBC
1 75.5 (CH) 4.01 (s) H-2, H-3, H-
10, H-10a 
2 26.9 (CH2) 1.62 (m, ) 
2.21 (d, 14.5, ) 
H-3, H-3, H-
4, H-4  
3 18.9 (CH2) 1.21 (d, 13.5, ) 
1.82 (m, ) 
H-1, H-2, H-
4, H-4 
4 53.6 (CH2) 2.87 (m, ) 
3.02 (m, ) 
H-3, H-3, H-
6, H-6 
6 53.0 (CH2) 3.38 (t, 13, )  
2.96 (m, ) 
H-4, H-4, H-
7, H-7, H-8, 
H-8 
7 27.0 (CH2) 2.03 (m, )  
1.66 (m, ) 
H-6, H-6, H-
8, H-8 
8 33.9 (CH2) 2.36 (dd, 4.5, 13.5, 
)  
1.75 (m, ) 
H-6, H-6, H-
7, H-7, H-10, 
H-10a  
9 120.4 (C)  H-7, H-8, H-
8, H-10, H-
10a, H-11 
10 57.0 (CH) 2.65 (d, 4.5) H-8, H-8, H-
10a, H-11, Me 
(18) 
10a 62.0 (CH) 3.44 (s) H-2, H-6, H-
10, H-11  
11 39.3 (CH) 3.07 (quin, 6.5) H-10, H-10a,  
Me (18) 
12 147.2 (C)  H-10, H-11, Me 
(17), Me (18) 
13 124.9 (C)  H-11, Me (17) 
14 162.7 (C)  OMe, Me (17) 
15 97.3 (C)  Me (17) 
16 169.8 (C)  Me (17) 
17 9.2 (CH3) 2.08 (s) OMe 
18 22.6 (CH3) 1.37 (d, 7) H-10, H-11 
OMe 58.9 (CH3) 4.15 (s)  
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CAPTION FOR X-RAY STRUCTURE: 
Figure 1. Molecular projection of stemocurtisine (2) showing 50% probability 
amplitude ellipsoids for C,N,O, hydrogen atoms having arbitrary radii of 0.1 Å. 
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Figure 2. Molecular model (AM1, Spartan) of the A,B,C-ring substructure of 2 
showing significant NOESY cross peaks (curved lines). 
